SELLAS Life Sciences Group, Inc. (SLS)
11.54
-1.94
(-14.42%)
USD |
NASDAQ |
Sep 11, 16:00
11.56
+0.02
(+0.13%)
After-Hours: 20:00
SELLAS Life Sciences Group Market Cap : 2.331B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.331B |
| September 10, 2026 | 2.724B |
| September 09, 2026 | 2.817B |
| September 08, 2026 | 2.819B |
| September 04, 2026 | 2.799B |
| September 03, 2026 | 2.766B |
| September 02, 2026 | 2.859B |
| September 01, 2026 | 2.669B |
| August 31, 2026 | 2.694B |
| August 28, 2026 | 2.667B |
| August 27, 2026 | 3.071B |
| August 26, 2026 | 2.772B |
| August 25, 2026 | 2.845B |
| August 24, 2026 | 2.892B |
| August 21, 2026 | 3.122B |
| August 20, 2026 | 2.706B |
| August 19, 2026 | 2.797B |
| August 18, 2026 | 2.645B |
| August 17, 2026 | 2.625B |
| August 14, 2026 | 2.581B |
| August 13, 2026 | 2.496B |
| August 12, 2026 | 2.377B |
| August 11, 2026 | 2.231B |
| August 10, 2026 | 2.229B |
| August 07, 2026 | 2.425B |
| Date | Value |
|---|---|
| August 06, 2026 | 2.362B |
| August 05, 2026 | 2.151B |
| August 04, 2026 | 2.142B |
| August 03, 2026 | 2.035B |
| July 31, 2026 | 1.815B |
| July 30, 2026 | 1.866B |
| July 29, 2026 | 1.831B |
| July 28, 2026 | 1.830B |
| July 27, 2026 | 1.965B |
| July 24, 2026 | 2.053B |
| July 23, 2026 | 2.238B |
| July 22, 2026 | 2.190B |
| July 21, 2026 | 2.339B |
| July 20, 2026 | 2.262B |
| July 17, 2026 | 2.392B |
| July 16, 2026 | 2.131B |
| July 15, 2026 | 2.319B |
| July 14, 2026 | 2.428B |
| July 13, 2026 | 2.288B |
| July 10, 2026 | 2.314B |
| July 09, 2026 | 2.450B |
| July 08, 2026 | 2.495B |
| July 07, 2026 | 2.448B |
| July 06, 2026 | 2.528B |
| July 02, 2026 | 2.716B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lite Strategy, Inc. | 39.02M |
| AbbVie, Inc. | 454.35B |
| Marker Therapeutics, Inc. | 19.17M |
| TG Therapeutics, Inc. | 8.249B |
| Rezolute, Inc. | 406.35M |
Market Cap Related Metrics
| Price to Book Value | 16.93 |
| Price | 11.54 |
| Earnings Yield | -1.84% |